Novel motif:110: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:07, 9 September 2013
name: | motif110_AGTCGCAGCG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 4.462687e-10 |
GO:0019087 | transformation of host cell by virus | 8.748418e-10 |
GO:0019048 | virus-host interaction | 2.691059e-8 |
GO:0016569 | covalent chromatin modification | 3.636327e-8 |
GO:0042254 | ribosome biogenesis | 4.809796e-8 |
GO:0016570 | histone modification | 5.758828e-8 |
GO:0042255 | ribosome assembly | 7.019678e-8 |
GO:0018026 | peptidyl-lysine monomethylation | 1.740110e-7 |
GO:0018022 | peptidyl-lysine methylation | 1.864553e-7 |
GO:0043414 | macromolecule methylation | 3.691080e-7 |
GO:0002149 | hypochlorous acid biosynthetic process | 3.887319e-7 |
GO:0090141 | positive regulation of mitochondrial fission | 3.906543e-7 |
GO:0006369 | termination of RNA polymerase II transcription | 4.131103e-7 |
GO:0018027 | peptidyl-lysine dimethylation | 6.696126e-7 |
GO:0061157 | mRNA destabilization | 8.834876e-7 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 8.834876e-7 |
GO:0006479 | protein methylation | 1.104506e-6 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.458925e-6 |
GO:0016571 | histone methylation | 1.525280e-6 |
GO:0002679 | respiratory burst involved in defense response | 1.542216e-6 |
GO:0032042 | mitochondrial DNA metabolic process | 1.603504e-6 |
GO:0010523 | negative regulation of calcium ion transport into cytosol | 2.377516e-6 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 4.243192e-6 |
GO:0051013 | microtubule severing | 6.293816e-6 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 6.311356e-6 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 6.611140e-6 |
GO:0090140 | regulation of mitochondrial fission | 6.919786e-6 |
GO:0065002 | intracellular protein transmembrane transport | 9.002538e-6 |
GO:0006264 | mitochondrial DNA replication | 9.436916e-6 |
GO:0021526 | medial motor column neuron differentiation | 1.202417e-5 |
GO:0048102 | autophagic cell death | 1.294042e-5 |
GO:0018119 | peptidyl-cysteine S-nitrosylation | 1.345093e-5 |
GO:0001830 | trophectodermal cell fate commitment | 1.434184e-5 |
GO:0044088 | regulation of vacuole organization | 1.744306e-5 |
GO:0034969 | histone arginine methylation | 1.938563e-5 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 1.977129e-5 |
GO:0070079 | histone H4-R3 demethylation | 3.002519e-5 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 3.002519e-5 |
GO:0070078 | histone H3-R2 demethylation | 3.002519e-5 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 3.478237e-5 |
GO:0046416 | D-amino acid metabolic process | 3.478237e-5 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 3.478237e-5 |
GO:0042093 | T-helper cell differentiation | 3.667192e-5 |
GO:0071169 | establishment of protein localization to chromatin | 3.784259e-5 |
GO:0070979 | protein K11-linked ubiquitination | 4.018530e-5 |
GO:0018198 | peptidyl-cysteine modification | 4.366392e-5 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 4.620652e-5 |
GO:0032383 | regulation of intracellular cholesterol transport | 4.720919e-5 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 4.971147e-5 |
GO:0071460 | cellular response to cell-matrix adhesion | 5.279147e-5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.312794e-5 |
GO:0043985 | histone H4-R3 methylation | 5.453193e-5 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 5.607590e-5 |
GO:0090311 | regulation of protein deacetylation | 5.771347e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 5.850745e-5 |
GO:0016577 | histone demethylation | 5.951441e-5 |
GO:0019428 | allantoin biosynthetic process | 6.313020e-5 |
GO:0071279 | cellular response to cobalt ion | 6.313020e-5 |
GO:0010637 | negative regulation of mitochondrial fusion | 6.313020e-5 |
GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process | 6.702795e-5 |
GO:0090344 | negative regulation of cell aging | 6.769986e-5 |
GO:0043084 | penile erection | 7.340071e-5 |
GO:0007288 | sperm axoneme assembly | 8.169045e-5 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 8.177600e-5 |
GO:2000143 | negative regulation of transcription initiation, DNA-dependent | 8.286316e-5 |
GO:0006478 | peptidyl-tyrosine sulfation | 8.787854e-5 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 8.955102e-5 |
GO:0035304 | regulation of protein dephosphorylation | 9.303906e-5 |
GO:0035364 | thymine transport | 9.818835e-5 |
GO:0035344 | hypoxanthine transport | 9.818835e-5 |
GO:0015854 | guanine transport | 9.818835e-5 |
GO:0006481 | C-terminal protein methylation | 1.010362e-4 |
GO:0060999 | positive regulation of dendritic spine development | 1.043713e-4 |
GO:0035306 | positive regulation of dephosphorylation | 1.079434e-4 |
GO:0046684 | response to pyrethroid | 1.100939e-4 |
GO:0060033 | anatomical structure regression | 1.152929e-4 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.249411e-4 |
GO:0016072 | rRNA metabolic process | 1.297872e-4 |
GO:0061013 | regulation of mRNA catabolic process | 1.409361e-4 |
GO:0090103 | cochlea morphogenesis | 1.446809e-4 |
GO:0006364 | rRNA processing | 1.493648e-4 |
GO:0090312 | positive regulation of protein deacetylation | 1.544977e-4 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.629388e-4 |
GO:0009785 | blue light signaling pathway | 1.634060e-4 |
GO:0051457 | maintenance of protein location in nucleus | 1.726885e-4 |
GO:0008298 | intracellular mRNA localization | 1.747651e-4 |
GO:0061032 | visceral serous pericardium development | 1.789691e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.789691e-4 |
GO:0035606 | peptidyl-cysteine S-trans-nitrosylation | 1.789691e-4 |
GO:0070179 | D-serine biosynthetic process | 1.870221e-4 |
GO:0031118 | rRNA pseudouridine synthesis | 1.870221e-4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.917276e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 1.993627e-4 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 2.127304e-4 |
GO:0043949 | regulation of cAMP-mediated signaling | 2.269987e-4 |
GO:0006482 | protein demethylation | 2.281054e-4 |
GO:0021986 | habenula development | 2.558463e-4 |
GO:0035470 | positive regulation of vascular wound healing | 2.563638e-4 |
GO:0051028 | mRNA transport | 2.603037e-4 |
GO:0034968 | histone lysine methylation | 2.628700e-4 |
GO:0051290 | protein heterotetramerization | 2.696266e-4 |
GO:0046732 | active induction of host immune response by virus | 2.733341e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 2.784274e-4 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 2.797884e-4 |
GO:0071294 | cellular response to zinc ion | 2.808872e-4 |
GO:0006406 | mRNA export from nucleus | 2.810598e-4 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 3.015989e-4 |
GO:0016598 | protein arginylation | 3.129413e-4 |
GO:0048050 | post-embryonic eye morphogenesis | 3.178407e-4 |
GO:0006403 | RNA localization | 3.238276e-4 |
GO:0035329 | hippo signaling cascade | 3.293696e-4 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 3.371186e-4 |
GO:0042766 | nucleosome mobilization | 3.390389e-4 |
GO:0008078 | mesodermal cell migration | 3.414144e-4 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 3.420416e-4 |
GO:0032094 | response to food | 4.121290e-4 |
GO:0046730 | induction of host immune response by virus | 4.346373e-4 |
GO:0090342 | regulation of cell aging | 4.346728e-4 |
GO:0008535 | respiratory chain complex IV assembly | 4.354614e-4 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 4.398543e-4 |
GO:0006188 | IMP biosynthetic process | 4.737995e-4 |
GO:0001840 | neural plate development | 5.114825e-4 |
GO:0090102 | cochlea development | 5.223049e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 5.447315e-4 |
GO:0019088 | immortalization of host cell by virus | 5.447579e-4 |
GO:0006231 | dTMP biosynthetic process | 5.447579e-4 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 5.457112e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 5.457112e-4 |
GO:0061014 | positive regulation of mRNA catabolic process | 5.476073e-4 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 6.017496e-4 |
GO:0097152 | mesenchymal cell apoptosis | 6.017496e-4 |
GO:0046078 | dUMP metabolic process | 6.017496e-4 |
GO:0060982 | coronary artery morphogenesis | 6.017496e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 6.047557e-4 |
GO:0001975 | response to amphetamine | 6.276898e-4 |
GO:0006844 | acyl carnitine transport | 6.345606e-4 |
GO:0006430 | lysyl-tRNA aminoacylation | 6.345606e-4 |
GO:0072166 | posterior mesonephric tubule development | 6.547065e-4 |
GO:0060242 | contact inhibition | 6.547065e-4 |
GO:0021644 | vagus nerve morphogenesis | 6.547065e-4 |
GO:0090129 | positive regulation of synapse maturation | 6.746095e-4 |
GO:0015886 | heme transport | 6.830131e-4 |
GO:0060744 | mammary gland branching involved in thelarche | 6.905867e-4 |
GO:0048268 | clathrin coat assembly | 6.999203e-4 |
GO:0035814 | negative regulation of renal sodium excretion | 7.022778e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 7.036904e-4 |
GO:0010742 | macrophage derived foam cell differentiation | 7.556927e-4 |
GO:0031063 | regulation of histone deacetylation | 7.572238e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.900137e-4 |
GO:0048210 | Golgi vesicle fusion to target membrane | 7.985278e-4 |
GO:0007182 | common-partner SMAD protein phosphorylation | 8.396633e-4 |
GO:0016241 | regulation of macroautophagy | 8.468638e-4 |
GO:0002513 | tolerance induction to self antigen | 8.568943e-4 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 8.753752e-4 |
GO:0051102 | DNA ligation involved in DNA recombination | 9.065106e-4 |
GO:0009405 | pathogenesis | 9.114235e-4 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 9.572535e-4 |
GO:0009637 | response to blue light | 9.869607e-4 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 9.979019e-4 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.002457e-3 |
GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter | 1.012198e-3 |
GO:0006529 | asparagine biosynthetic process | 1.072808e-3 |
GO:0001842 | neural fold formation | 1.104037e-3 |
GO:0034470 | ncRNA processing | 1.124372e-3 |
GO:0051645 | Golgi localization | 1.197766e-3 |
GO:0045064 | T-helper 2 cell differentiation | 1.197766e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.197766e-3 |
GO:0031427 | response to methotrexate | 1.205834e-3 |
GO:0043932 | ossification involved in bone remodeling | 1.222789e-3 |
GO:0006177 | GMP biosynthetic process | 1.269276e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.466297e-3 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 1.491875e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 1.588403e-3 |
GO:0070734 | histone H3-K27 methylation | 1.588403e-3 |
GO:0003326 | pancreatic A cell fate commitment | 1.588403e-3 |
GO:0040040 | thermosensory behavior | 1.730157e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 1.730157e-3 |
GO:0002293 | alpha-beta T cell differentiation involved in immune response | 1.742742e-3 |
GO:0060976 | coronary vasculature development | 1.744791e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.777196e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 1.777827e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.805855e-3 |
GO:0090128 | regulation of synapse maturation | 1.845475e-3 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 1.916134e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.916134e-3 |
GO:0030704 | vitelline membrane formation | 1.916134e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 1.916134e-3 |
GO:0042274 | ribosomal small subunit biogenesis | 1.956522e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.961051e-3 |
GO:0006670 | sphingosine metabolic process | 1.987797e-3 |
GO:0033233 | regulation of protein sumoylation | 2.052672e-3 |
GO:0006533 | aspartate catabolic process | 2.071143e-3 |
GO:0010835 | regulation of protein ADP-ribosylation | 2.121699e-3 |
GO:0035425 | autocrine signaling | 2.121699e-3 |
GO:0001839 | neural plate morphogenesis | 2.155979e-3 |
GO:0090303 | positive regulation of wound healing | 2.176232e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.200668e-3 |
GO:0010765 | positive regulation of sodium ion transport | 2.278917e-3 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 2.308956e-3 |
GO:0006287 | base-excision repair, gap-filling | 2.308956e-3 |
GO:0021506 | anterior neuropore closure | 2.315491e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 2.409085e-3 |
GO:0007184 | SMAD protein import into nucleus | 2.421461e-3 |
GO:0007549 | dosage compensation | 2.490492e-3 |
GO:0031065 | positive regulation of histone deacetylation | 2.548270e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 2.559748e-3 |
GO:0018283 | iron incorporation into metallo-sulfur cluster | 2.614462e-3 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 2.636229e-3 |
GO:0006405 | RNA export from nucleus | 2.703730e-3 |
GO:0035852 | horizontal cell localization | 2.705232e-3 |
GO:0080009 | mRNA methylation | 2.705232e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 2.705232e-3 |
GO:0035849 | nephric duct elongation | 2.705232e-3 |
GO:0035847 | uterine epithelium development | 2.705232e-3 |
GO:0006781 | succinyl-CoA pathway | 2.705232e-3 |
GO:0035502 | metanephric ureteric bud development | 2.705232e-3 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 2.705232e-3 |
GO:0035846 | oviduct epithelium development | 2.705232e-3 |
GO:0045329 | carnitine biosynthetic process | 2.729287e-3 |
GO:0015862 | uridine transport | 2.866924e-3 |
GO:0006984 | ER-nucleus signaling pathway | 2.905035e-3 |
GO:0034401 | regulation of transcription by chromatin organization | 2.911393e-3 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 2.911393e-3 |
GO:0043174 | nucleoside salvage | 2.946091e-3 |
GO:0001829 | trophectodermal cell differentiation | 2.948048e-3 |
GO:0051586 | positive regulation of dopamine uptake | 3.092025e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 3.092025e-3 |
GO:0002268 | follicular dendritic cell differentiation | 3.128092e-3 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 3.163193e-3 |
GO:0032060 | bleb assembly | 3.163193e-3 |
GO:0060009 | Sertoli cell development | 3.272695e-3 |
GO:0021784 | postganglionic parasympathetic nervous system development | 3.286589e-3 |
GO:0048486 | parasympathetic nervous system development | 3.336608e-3 |
GO:0021568 | rhombomere 2 development | 3.396087e-3 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 3.431521e-3 |
GO:0045403 | negative regulation of interleukin-4 biosynthetic process | 3.431521e-3 |
GO:2000002 | negative regulation of DNA damage checkpoint | 3.431521e-3 |
GO:0060377 | negative regulation of mast cell differentiation | 3.431521e-3 |
GO:0021588 | cerebellum formation | 3.431521e-3 |
GO:0021551 | central nervous system morphogenesis | 3.431521e-3 |
GO:0003192 | mitral valve formation | 3.431521e-3 |
GO:0002295 | T-helper cell lineage commitment | 3.431521e-3 |
GO:0003195 | tricuspid valve formation | 3.431521e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 3.507598e-3 |
GO:0035803 | egg coat formation | 3.516074e-3 |
GO:0007100 | mitotic centrosome separation | 3.516074e-3 |
GO:0003175 | tricuspid valve development | 3.737739e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 3.889655e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 3.895218e-3 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 3.895218e-3 |
GO:0071281 | cellular response to iron ion | 3.931692e-3 |
GO:0043097 | pyrimidine nucleoside salvage | 3.988532e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 4.133766e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 4.280107e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 4.280107e-3 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 4.280107e-3 |
GO:0042256 | mature ribosome assembly | 4.283652e-3 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 4.283652e-3 |
GO:0006301 | postreplication repair | 4.283985e-3 |
GO:0033058 | directional locomotion | 4.377237e-3 |
GO:0034770 | histone H4-K20 methylation | 4.388601e-3 |
GO:0015789 | UDP-N-acetylgalactosamine transport | 4.465280e-3 |
GO:0015787 | UDP-glucuronic acid transport | 4.465280e-3 |
GO:0050658 | RNA transport | 4.488775e-3 |
GO:0000002 | mitochondrial genome maintenance | 4.670718e-3 |
GO:0030433 | ER-associated protein catabolic process | 4.695090e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 4.755816e-3 |
GO:0045351 | type I interferon biosynthetic process | 4.756093e-3 |
GO:0006730 | one-carbon metabolic process | 4.793505e-3 |
GO:0035725 | sodium ion transmembrane transport | 4.802170e-3 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 5.121262e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 5.188445e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 5.201996e-3 |
GO:0010756 | positive regulation of plasminogen activation | 5.237435e-3 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 5.397777e-3 |
GO:0060455 | negative regulation of gastric acid secretion | 5.397777e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 5.397777e-3 |
GO:0010225 | response to UV-C | 5.404788e-3 |
GO:0000387 | spliceosomal snRNP assembly | 5.407399e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 5.408803e-3 |
GO:0060711 | labyrinthine layer development | 5.430105e-3 |
GO:0042711 | maternal behavior | 5.455325e-3 |
GO:0009437 | carnitine metabolic process | 5.488590e-3 |
GO:0021615 | glossopharyngeal nerve morphogenesis | 5.495578e-3 |
GO:0006610 | ribosomal protein import into nucleus | 5.536567e-3 |
GO:0022415 | viral reproductive process | 5.549848e-3 |
GO:0045136 | development of secondary sexual characteristics | 5.586135e-3 |
GO:0003311 | pancreatic D cell differentiation | 5.614773e-3 |
GO:0090104 | pancreatic E cell differentiation | 5.614773e-3 |
GO:0000027 | ribosomal large subunit assembly | 5.614773e-3 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 5.718728e-3 |
GO:0032259 | methylation | 5.806815e-3 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 5.959340e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 5.959340e-3 |
GO:0045472 | response to ether | 5.959340e-3 |
GO:0061302 | smooth muscle cell-matrix adhesion | 5.959340e-3 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 6.081920e-3 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 6.126807e-3 |
GO:0032244 | positive regulation of nucleoside transport | 6.156350e-3 |
GO:0032900 | negative regulation of neurotrophin production | 6.156350e-3 |
GO:0070925 | organelle assembly | 6.301795e-3 |
GO:0071542 | dopaminergic neuron differentiation | 6.337274e-3 |
GO:0014037 | Schwann cell differentiation | 6.358717e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 6.417419e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 6.417419e-3 |
GO:0010836 | negative regulation of protein ADP-ribosylation | 6.417419e-3 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 6.457761e-3 |
GO:0034970 | histone H3-R2 methylation | 6.594852e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 6.623807e-3 |
GO:0046784 | intronless viral mRNA export from host nucleus | 6.681651e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 6.681651e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.723181e-3 |
GO:0010498 | proteasomal protein catabolic process | 6.795613e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 6.837192e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 7.121601e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 7.179283e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 7.179283e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 7.335075e-3 |
GO:0060017 | parathyroid gland development | 7.595681e-3 |
GO:0061084 | negative regulation of protein refolding | 7.689192e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 7.689192e-3 |
GO:0006004 | fucose metabolic process | 7.887068e-3 |
GO:0071585 | detoxification of cadmium ion | 7.973502e-3 |
GO:0032264 | IMP salvage | 7.973502e-3 |
GO:0032263 | GMP salvage | 7.973502e-3 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 8.021330e-3 |
GO:0006171 | cAMP biosynthetic process | 8.108122e-3 |
GO:0016568 | chromatin modification | 8.114151e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 8.151684e-3 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 8.247878e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 8.247878e-3 |
GO:0001941 | postsynaptic membrane organization | 8.404457e-3 |
GO:0021819 | layer formation in cerebral cortex | 8.427207e-3 |
GO:0016925 | protein sumoylation | 8.467904e-3 |
GO:0046037 | GMP metabolic process | 8.529071e-3 |
GO:0042053 | regulation of dopamine metabolic process | 8.645244e-3 |
GO:0071280 | cellular response to copper ion | 8.653347e-3 |
GO:0016559 | peroxisome fission | 8.653347e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 8.678662e-3 |
GO:0070534 | protein K63-linked ubiquitination | 8.789049e-3 |
GO:0046796 | viral genome transport in host cell | 8.821411e-3 |
GO:0043519 | regulation of myosin II filament organization | 8.821411e-3 |
GO:0007406 | negative regulation of neuroblast proliferation | 9.054373e-3 |
GO:0050775 | positive regulation of dendrite morphogenesis | 9.097419e-3 |
GO:0006379 | mRNA cleavage | 9.159141e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 9.171737e-3 |
GO:0070988 | demethylation | 9.294646e-3 |
GO:0060998 | regulation of dendritic spine development | 9.294850e-3 |
GO:0060136 | embryonic process involved in female pregnancy | 9.309227e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 9.423584e-3 |
GO:0046174 | polyol catabolic process | 9.423584e-3 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 9.468404e-3 |
GO:0043148 | mitotic spindle stabilization | 9.475189e-3 |
GO:0035522 | monoubiquitinated histone H2A deubiquitination | 9.475189e-3 |
GO:0006545 | glycine biosynthetic process | 9.499049e-3 |
GO:0006544 | glycine metabolic process | 9.654702e-3 |
GO:0006013 | mannose metabolic process | 1.002757e-2 |
GO:0043353 | enucleate erythrocyte differentiation | 1.018701e-2 |
GO:0010822 | positive regulation of mitochondrion organization | 1.023011e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.038796e-2 |
GO:0010722 | regulation of ferrochelatase activity | 1.038796e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.038796e-2 |
GO:0050685 | positive regulation of mRNA processing | 1.045072e-2 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1.047852e-2 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.051121e-2 |
GO:0051463 | negative regulation of cortisol secretion | 1.091870e-2 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.091870e-2 |
GO:0060125 | negative regulation of growth hormone secretion | 1.091870e-2 |
GO:0034971 | histone H3-R17 methylation | 1.091870e-2 |
GO:0000088 | mitotic prophase | 1.091870e-2 |
GO:0006178 | guanine salvage | 1.091870e-2 |
GO:0046038 | GMP catabolic process | 1.091870e-2 |
GO:0030851 | granulocyte differentiation | 1.097494e-2 |
GO:0060623 | regulation of chromosome condensation | 1.102730e-2 |
GO:0071283 | cellular response to iron(III) ion | 1.102730e-2 |
GO:2000009 | negative regulation of protein localization at cell surface | 1.102730e-2 |
GO:0046680 | response to DDT | 1.102730e-2 |
GO:0018872 | arsonoacetate metabolic process | 1.102730e-2 |
GO:0043456 | regulation of pentose-phosphate shunt | 1.102730e-2 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 1.102730e-2 |
GO:0014733 | regulation of skeletal muscle adaptation | 1.124869e-2 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.130869e-2 |
GO:0048561 | establishment of organ orientation | 1.165504e-2 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 1.165504e-2 |
GO:0019478 | D-amino acid catabolic process | 1.165504e-2 |
GO:0019405 | alditol catabolic process | 1.165504e-2 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 1.165504e-2 |
GO:0007343 | egg activation | 1.170764e-2 |
GO:0042414 | epinephrine metabolic process | 1.183191e-2 |
GO:0003094 | glomerular filtration | 1.183191e-2 |
GO:0071514 | genetic imprinting | 1.184756e-2 |
GO:0015827 | tryptophan transport | 1.192131e-2 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 1.231214e-2 |
GO:2000772 | regulation of cellular senescence | 1.269233e-2 |
GO:0018216 | peptidyl-arginine methylation | 1.273905e-2 |
GO:0042069 | regulation of catecholamine metabolic process | 1.281181e-2 |
GO:0035928 | rRNA import into mitochondrion | 1.322126e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.329506e-2 |
GO:0034660 | ncRNA metabolic process | 1.330411e-2 |
GO:0051567 | histone H3-K9 methylation | 1.349556e-2 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 1.352796e-2 |
GO:0035246 | peptidyl-arginine N-methylation | 1.372482e-2 |
GO:0044003 | modification by symbiont of host morphology or physiology | 1.379576e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.385587e-2 |
GO:0061100 | lung neuroendocrine cell differentiation | 1.391699e-2 |
GO:0061102 | stomach neuroendocrine cell differentiation | 1.391699e-2 |
GO:0071259 | cellular response to magnetism | 1.391699e-2 |
GO:0061104 | adrenal chromaffin cell differentiation | 1.391699e-2 |
GO:0061103 | carotid body glomus cell differentiation | 1.391699e-2 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 1.391699e-2 |
GO:0003359 | noradrenergic neuron fate commitment | 1.391699e-2 |
GO:0007400 | neuroblast fate determination | 1.391699e-2 |
GO:0008292 | acetylcholine biosynthetic process | 1.391699e-2 |
GO:0060163 | subpallium neuron fate commitment | 1.391699e-2 |
GO:0021932 | hindbrain radial glia guided cell migration | 1.407104e-2 |
GO:0014044 | Schwann cell development | 1.419912e-2 |
GO:0035372 | protein localization to microtubule | 1.425864e-2 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.429356e-2 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.429356e-2 |
GO:0043973 | histone H3-K4 acetylation | 1.429356e-2 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.429356e-2 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1.431933e-2 |
GO:0009440 | cyanate catabolic process | 1.431933e-2 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.434935e-2 |
GO:0042273 | ribosomal large subunit biogenesis | 1.478905e-2 |
GO:0042074 | cell migration involved in gastrulation | 1.501002e-2 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.501175e-2 |
GO:0043045 | DNA methylation involved in embryo development | 1.501175e-2 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 1.547183e-2 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 1.596468e-2 |
GO:0032025 | response to cobalt ion | 1.631397e-2 |
GO:0045836 | positive regulation of meiosis | 1.637303e-2 |
GO:0044342 | type B pancreatic cell proliferation | 1.644821e-2 |
GO:0015680 | intracellular copper ion transport | 1.644821e-2 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 1.644821e-2 |
GO:0060977 | coronary vasculature morphogenesis | 1.694947e-2 |
GO:0006085 | acetyl-CoA biosynthetic process | 1.694947e-2 |
GO:0021542 | dentate gyrus development | 1.708234e-2 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.718946e-2 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 1.726381e-2 |
GO:0016561 | protein import into peroxisome matrix, translocation | 1.726381e-2 |
GO:0007191 | activation of adenylate cyclase activity by dopamine receptor signaling pathway | 1.740769e-2 |
GO:0001825 | blastocyst formation | 1.744238e-2 |
GO:0018205 | peptidyl-lysine modification | 1.746089e-2 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 1.747420e-2 |
GO:0051030 | snRNA transport | 1.768737e-2 |
GO:0006189 | 'de novo' IMP biosynthetic process | 1.768737e-2 |
GO:0035511 | oxidative DNA demethylation | 1.776245e-2 |
GO:0045792 | negative regulation of cell size | 1.784010e-2 |
GO:0035308 | negative regulation of protein dephosphorylation | 1.806076e-2 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.818664e-2 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 1.826980e-2 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 1.826980e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.838941e-2 |
GO:0033120 | positive regulation of RNA splicing | 1.877064e-2 |
GO:0016926 | protein desumoylation | 1.877262e-2 |
GO:0005978 | glycogen biosynthetic process | 1.890003e-2 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 1.914494e-2 |
GO:0031557 | induction of programmed cell death in response to chemical stimulus | 1.931640e-2 |
GO:0043308 | eosinophil degranulation | 1.946539e-2 |
GO:0042796 | snRNA transcription from RNA polymerase III promoter | 1.946539e-2 |
GO:0046674 | induction of retinal programmed cell death | 1.946539e-2 |
GO:0051885 | positive regulation of anagen | 1.946539e-2 |
GO:0042795 | snRNA transcription from RNA polymerase II promoter | 1.946539e-2 |
GO:0048597 | post-embryonic camera-type eye morphogenesis | 1.946539e-2 |
GO:0001777 | T cell homeostatic proliferation | 1.946539e-2 |
GO:0002352 | B cell negative selection | 1.946539e-2 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.946539e-2 |
GO:0014835 | myoblast cell differentiation involved in skeletal muscle regeneration | 1.946539e-2 |
GO:0001579 | medium-chain fatty acid transport | 1.946539e-2 |
GO:0021764 | amygdala development | 1.946539e-2 |
GO:0032976 | release of matrix enzymes from mitochondria | 1.946539e-2 |
GO:0070904 | transepithelial L-ascorbic acid transport | 2.001226e-2 |
GO:0046604 | positive regulation of mitotic centrosome separation | 2.023230e-2 |
GO:0034351 | negative regulation of glial cell apoptosis | 2.023230e-2 |
GO:0045200 | establishment of neuroblast polarity | 2.023230e-2 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 2.026286e-2 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.037545e-2 |
GO:0060311 | negative regulation of elastin catabolic process | 2.063284e-2 |
GO:0060313 | negative regulation of blood vessel remodeling | 2.063284e-2 |
GO:0000917 | barrier septum formation | 2.063284e-2 |
GO:0010711 | negative regulation of collagen catabolic process | 2.063284e-2 |
GO:0010703 | negative regulation of histolysis | 2.063284e-2 |
GO:0002071 | glandular epithelial cell maturation | 2.063284e-2 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 2.084663e-2 |
GO:0007020 | microtubule nucleation | 2.085276e-2 |
GO:0042088 | T-helper 1 type immune response | 2.091743e-2 |
GO:0021603 | cranial nerve formation | 2.095393e-2 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 2.096858e-2 |
GO:0007023 | post-chaperonin tubulin folding pathway | 2.130110e-2 |
GO:0019230 | proprioception | 2.187838e-2 |
GO:0022011 | myelination in peripheral nervous system | 2.192152e-2 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 2.194745e-2 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 2.202587e-2 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.211589e-2 |
GO:0060450 | positive regulation of hindgut contraction | 2.212339e-2 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 2.212339e-2 |
GO:0051793 | medium-chain fatty acid catabolic process | 2.212339e-2 |
GO:0045925 | positive regulation of female receptivity | 2.212339e-2 |
GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA | 2.212339e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016926 | protein desumoylation | 2.496775e-9 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.403076e-8 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.200637e-7 |
GO:0014056 | regulation of acetylcholine secretion | 3.365286e-7 |
GO:0018023 | peptidyl-lysine trimethylation | 3.988142e-7 |
GO:0018364 | peptidyl-glutamine methylation | 4.404722e-7 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 5.818532e-7 |
GO:0060136 | embryonic process involved in female pregnancy | 7.867469e-7 |
GO:0014051 | gamma-aminobutyric acid secretion | 1.009300e-6 |
GO:0043587 | tongue morphogenesis | 1.269432e-6 |
GO:0046605 | regulation of centrosome cycle | 3.352723e-6 |
GO:0006344 | maintenance of chromatin silencing | 3.665346e-6 |
GO:0006287 | base-excision repair, gap-filling | 6.925983e-6 |
GO:0007183 | SMAD protein complex assembly | 7.520407e-6 |
GO:0090084 | negative regulation of inclusion body assembly | 1.048965e-5 |
GO:0034502 | protein localization to chromosome | 1.185881e-5 |
GO:0046599 | regulation of centriole replication | 1.364852e-5 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 1.509429e-5 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.778636e-5 |
GO:0051103 | DNA ligation involved in DNA repair | 1.798064e-5 |
GO:0019348 | dolichol metabolic process | 1.999066e-5 |
GO:0051586 | positive regulation of dopamine uptake | 2.186377e-5 |
GO:0060390 | regulation of SMAD protein import into nucleus | 3.608851e-5 |
GO:0015812 | gamma-aminobutyric acid transport | 4.038962e-5 |
GO:0035990 | tendon cell differentiation | 4.127724e-5 |
GO:0035621 | ER to Golgi ceramide transport | 4.815421e-5 |
GO:0034227 | tRNA thio-modification | 5.599077e-5 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 5.599077e-5 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.735906e-5 |
GO:0007288 | sperm axoneme assembly | 6.661018e-5 |
GO:0003130 | BMP signaling pathway involved in heart induction | 7.309809e-5 |
GO:0000910 | cytokinesis | 7.644113e-5 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 7.790187e-5 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 7.790187e-5 |
GO:0072192 | ureter epithelial cell differentiation | 7.790187e-5 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 7.790187e-5 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 7.790187e-5 |
GO:0090194 | negative regulation of glomerulus development | 7.790187e-5 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 7.790187e-5 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 7.790187e-5 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 7.790187e-5 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 7.790187e-5 |
GO:0007500 | mesodermal cell fate determination | 7.790187e-5 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 7.790187e-5 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 7.790187e-5 |
GO:0048392 | intermediate mesodermal cell differentiation | 7.790187e-5 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 7.790187e-5 |
GO:0060503 | bud dilation involved in lung branching | 7.790187e-5 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 7.790187e-5 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 7.790187e-5 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 7.790187e-5 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 7.790187e-5 |
GO:0018243 | protein O-linked glycosylation via threonine | 7.828942e-5 |
GO:0018242 | protein O-linked glycosylation via serine | 7.828942e-5 |
GO:0021569 | rhombomere 3 development | 8.671619e-5 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 8.883056e-5 |
GO:0035993 | deltoid tuberosity development | 8.906479e-5 |
GO:0046785 | microtubule polymerization | 1.022625e-4 |
GO:0071169 | establishment of protein localization to chromatin | 1.072653e-4 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1.072653e-4 |
GO:0016142 | O-glycoside catabolic process | 1.101001e-4 |
GO:0002098 | tRNA wobble uridine modification | 1.117411e-4 |
GO:0001829 | trophectodermal cell differentiation | 1.331985e-4 |
GO:0046952 | ketone body catabolic process | 1.468622e-4 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.468622e-4 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 1.589148e-4 |
GO:0051881 | regulation of mitochondrial membrane potential | 1.601514e-4 |
GO:0006493 | protein O-linked glycosylation | 1.762077e-4 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.921655e-4 |
GO:0072205 | metanephric collecting duct development | 1.973415e-4 |
GO:0009798 | axis specification | 1.997118e-4 |
GO:0090169 | regulation of spindle assembly | 2.045244e-4 |
GO:0090234 | regulation of kinetochore assembly | 2.045244e-4 |
GO:0048671 | negative regulation of collateral sprouting | 2.165705e-4 |
GO:0032060 | bleb assembly | 2.165705e-4 |
GO:0009992 | cellular water homeostasis | 2.397126e-4 |
GO:0032446 | protein modification by small protein conjugation | 2.399333e-4 |
GO:0016567 | protein ubiquitination | 2.422380e-4 |
GO:0021578 | hindbrain maturation | 2.675007e-4 |
GO:0006266 | DNA ligation | 2.750419e-4 |
GO:0032287 | peripheral nervous system myelin maintenance | 2.844724e-4 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 2.874207e-4 |
GO:0010452 | histone H3-K36 methylation | 2.926717e-4 |
GO:0021750 | vestibular nucleus development | 3.108425e-4 |
GO:0021679 | cerebellar molecular layer development | 3.108425e-4 |
GO:0010936 | negative regulation of macrophage cytokine production | 3.108425e-4 |
GO:0021590 | cerebellum maturation | 3.108425e-4 |
GO:0019673 | GDP-mannose metabolic process | 3.108425e-4 |
GO:0060674 | placenta blood vessel development | 3.172672e-4 |
GO:0050765 | negative regulation of phagocytosis | 3.397426e-4 |
GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway | 3.544698e-4 |
GO:0021696 | cerebellar cortex morphogenesis | 3.637960e-4 |
GO:0032782 | bile acid secretion | 3.698505e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 3.698505e-4 |
GO:0003096 | renal sodium ion transport | 3.698505e-4 |
GO:0001579 | medium-chain fatty acid transport | 3.698505e-4 |
GO:0060024 | rhythmic synaptic transmission | 3.953387e-4 |
GO:0030501 | positive regulation of bone mineralization | 4.043444e-4 |
GO:0003254 | regulation of membrane depolarization | 4.620821e-4 |
GO:0048670 | regulation of collateral sprouting | 4.649032e-4 |
GO:0071922 | regulation of cohesin localization to chromatin | 5.130838e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 5.130838e-4 |
GO:0016068 | type I hypersensitivity | 5.167744e-4 |
GO:2000772 | regulation of cellular senescence | 5.191010e-4 |
GO:0035269 | protein O-linked mannosylation | 5.231294e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 5.255197e-4 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 5.529282e-4 |
GO:0042921 | glucocorticoid receptor signaling pathway | 5.637931e-4 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 5.645784e-4 |
GO:0046604 | positive regulation of mitotic centrosome separation | 5.716688e-4 |
GO:0070169 | positive regulation of biomineral tissue development | 5.863945e-4 |
GO:0021587 | cerebellum morphogenesis | 6.673066e-4 |
GO:0042136 | neurotransmitter biosynthetic process | 6.729233e-4 |
GO:0045662 | negative regulation of myoblast differentiation | 6.749006e-4 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 6.815049e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 6.905274e-4 |
GO:0071168 | protein localization to chromatin | 7.436829e-4 |
GO:0002832 | negative regulation of response to biotic stimulus | 7.439369e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 7.806794e-4 |
GO:0021707 | cerebellar granule cell differentiation | 7.831875e-4 |
GO:0006268 | DNA unwinding involved in replication | 7.831875e-4 |
GO:0006284 | base-excision repair | 7.840796e-4 |
GO:0060439 | trachea morphogenesis | 8.333169e-4 |
GO:0021506 | anterior neuropore closure | 8.656674e-4 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 8.918074e-4 |
GO:0035229 | positive regulation of glutamate-cysteine ligase activity | 8.964396e-4 |
GO:0021603 | cranial nerve formation | 9.208236e-4 |
GO:0071247 | cellular response to chromate | 9.569613e-4 |
GO:0032353 | negative regulation of hormone biosynthetic process | 9.723763e-4 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.017004e-3 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.017004e-3 |
GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway | 1.037497e-3 |
GO:0070078 | histone H3-R2 demethylation | 1.066863e-3 |
GO:0070079 | histone H4-R3 demethylation | 1.066863e-3 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.066863e-3 |
GO:0006713 | glucocorticoid catabolic process | 1.066863e-3 |
GO:0070286 | axonemal dynein complex assembly | 1.083211e-3 |
GO:0061154 | endothelial tube morphogenesis | 1.083211e-3 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 1.083211e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 1.083211e-3 |
GO:0010824 | regulation of centrosome duplication | 1.086241e-3 |
GO:0021610 | facial nerve morphogenesis | 1.156611e-3 |
GO:0055025 | positive regulation of cardiac muscle tissue development | 1.173729e-3 |
GO:0042660 | positive regulation of cell fate specification | 1.185247e-3 |
GO:0042053 | regulation of dopamine metabolic process | 1.185265e-3 |
GO:0021612 | facial nerve structural organization | 1.223048e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 1.224326e-3 |
GO:0010159 | specification of organ position | 1.224326e-3 |
GO:0014047 | glutamate secretion | 1.224326e-3 |
GO:2000425 | regulation of apoptotic cell clearance | 1.229106e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.236370e-3 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 1.239019e-3 |
GO:0031958 | corticosteroid receptor signaling pathway | 1.292275e-3 |
GO:0021548 | pons development | 1.399435e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 1.433139e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 1.459856e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 1.475774e-3 |
GO:0018210 | peptidyl-threonine modification | 1.500264e-3 |
GO:0071459 | protein localization to chromosome, centromeric region | 1.541874e-3 |
GO:0051301 | cell division | 1.697257e-3 |
GO:0034587 | piRNA metabolic process | 1.712841e-3 |
GO:0016140 | O-glycoside metabolic process | 1.732678e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.746587e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.795096e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.795096e-3 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.845805e-3 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 1.901912e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 2.019887e-3 |
GO:0060433 | bronchus development | 2.030852e-3 |
GO:0070179 | D-serine biosynthetic process | 2.064561e-3 |
GO:0031584 | activation of phospholipase D activity | 2.149104e-3 |
GO:0010870 | positive regulation of receptor biosynthetic process | 2.149555e-3 |
GO:0032967 | positive regulation of collagen biosynthetic process | 2.239124e-3 |
GO:0021683 | cerebellar granular layer morphogenesis | 2.275280e-3 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.275831e-3 |
GO:0009880 | embryonic pattern specification | 2.330582e-3 |
GO:0021697 | cerebellar cortex formation | 2.384298e-3 |
GO:0001975 | response to amphetamine | 2.391618e-3 |
GO:0043932 | ossification involved in bone remodeling | 2.635156e-3 |
GO:0032486 | Rap protein signal transduction | 2.648273e-3 |
GO:0042254 | ribosome biogenesis | 2.668279e-3 |
GO:0046836 | glycolipid transport | 2.834104e-3 |
GO:0060286 | flagellar cell motility | 2.834104e-3 |
GO:0008298 | intracellular mRNA localization | 2.834104e-3 |
GO:0002003 | angiotensin maturation | 2.834104e-3 |
GO:0061156 | pulmonary artery morphogenesis | 2.883313e-3 |
GO:0045116 | protein neddylation | 2.883313e-3 |
GO:0060440 | trachea formation | 2.911060e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 2.911060e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 2.911060e-3 |
GO:0035425 | autocrine signaling | 2.938284e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 2.938284e-3 |
GO:0048672 | positive regulation of collateral sprouting | 2.942562e-3 |
GO:0045221 | negative regulation of FasL biosynthetic process | 2.967124e-3 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 2.967124e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.967124e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.967124e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 2.967124e-3 |
GO:0048239 | negative regulation of DNA recombination at telomere | 2.967124e-3 |
GO:0002731 | negative regulation of dendritic cell cytokine production | 2.967124e-3 |
GO:0032707 | negative regulation of interleukin-23 production | 2.967124e-3 |
GO:0006430 | lysyl-tRNA aminoacylation | 2.967124e-3 |
GO:0030150 | protein import into mitochondrial matrix | 2.967124e-3 |
GO:0019676 | ammonia assimilation cycle | 2.967124e-3 |
GO:0070585 | protein localization in mitochondrion | 3.007605e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 3.078047e-3 |
GO:0070936 | protein K48-linked ubiquitination | 3.155966e-3 |
GO:0051168 | nuclear export | 3.165462e-3 |
GO:0048532 | anatomical structure arrangement | 3.368456e-3 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 3.416110e-3 |
GO:0008208 | C21-steroid hormone catabolic process | 3.425705e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 3.495783e-3 |
GO:0003161 | cardiac conduction system development | 3.584263e-3 |
GO:0021561 | facial nerve development | 3.592963e-3 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 3.615523e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 3.735910e-3 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 3.762140e-3 |
GO:0007422 | peripheral nervous system development | 3.812735e-3 |
GO:0007099 | centriole replication | 3.894024e-3 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 3.921905e-3 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 3.921905e-3 |
GO:2000426 | negative regulation of apoptotic cell clearance | 3.946602e-3 |
GO:0019049 | evasion of host defenses by virus | 3.946602e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 3.946602e-3 |
GO:0021575 | hindbrain morphogenesis | 3.953309e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 4.004056e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 4.004056e-3 |
GO:0071173 | spindle assembly checkpoint | 4.022682e-3 |
GO:0060384 | innervation | 4.118493e-3 |
GO:0035849 | nephric duct elongation | 4.218236e-3 |
GO:0035846 | oviduct epithelium development | 4.218236e-3 |
GO:0035847 | uterine epithelium development | 4.218236e-3 |
GO:0070370 | cellular heat acclimation | 4.218236e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 4.218236e-3 |
GO:0042335 | cuticle development | 4.218236e-3 |
GO:0035852 | horizontal cell localization | 4.218236e-3 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 4.218236e-3 |
GO:0008052 | sensory organ boundary specification | 4.218236e-3 |
GO:0007402 | ganglion mother cell fate determination | 4.218236e-3 |
GO:0015853 | adenine transport | 4.218236e-3 |
GO:0015854 | guanine transport | 4.218236e-3 |
GO:0035356 | cellular triglyceride homeostasis | 4.218236e-3 |
GO:0035344 | hypoxanthine transport | 4.218236e-3 |
GO:0035364 | thymine transport | 4.218236e-3 |
GO:0021695 | cerebellar cortex development | 4.401997e-3 |
GO:0001710 | mesodermal cell fate commitment | 4.577071e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 4.782707e-3 |
GO:0030219 | megakaryocyte differentiation | 4.945738e-3 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 5.214774e-3 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 5.214774e-3 |
GO:0021785 | branchiomotor neuron axon guidance | 5.238608e-3 |
GO:0032965 | regulation of collagen biosynthetic process | 5.294212e-3 |
GO:0060920 | pacemaker cell differentiation | 5.354530e-3 |
GO:0030038 | contractile actin filament bundle assembly | 5.533319e-3 |
GO:0035912 | dorsal aorta morphogenesis | 5.533319e-3 |
GO:0006611 | protein export from nucleus | 5.621626e-3 |
GO:0061004 | pattern specification involved in kidney development | 5.643704e-3 |
GO:0033083 | regulation of immature T cell proliferation | 5.673519e-3 |
GO:0021546 | rhombomere development | 5.673519e-3 |
GO:0009996 | negative regulation of cell fate specification | 5.673519e-3 |
GO:0046039 | GTP metabolic process | 5.803883e-3 |
GO:0018279 | protein N-linked glycosylation via asparagine | 6.308182e-3 |
GO:0022037 | metencephalon development | 6.351575e-3 |
GO:0048640 | negative regulation of developmental growth | 6.395435e-3 |
GO:0090083 | regulation of inclusion body assembly | 6.423194e-3 |
GO:0055119 | relaxation of cardiac muscle | 6.446204e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.511057e-3 |
GO:0048255 | mRNA stabilization | 6.528082e-3 |
GO:0035082 | axoneme assembly | 6.702487e-3 |
GO:0000917 | barrier septum formation | 6.776947e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 6.776947e-3 |
GO:0022417 | protein maturation by protein folding | 6.776947e-3 |
GO:0032415 | regulation of sodium:hydrogen antiporter activity | 6.786650e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 6.786650e-3 |
GO:0000089 | mitotic metaphase | 6.995492e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 7.034711e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 7.034711e-3 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 7.130055e-3 |
GO:0051176 | positive regulation of sulfur metabolic process | 7.131974e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 7.131974e-3 |
GO:0048389 | intermediate mesoderm development | 7.131974e-3 |
GO:0042256 | mature ribosome assembly | 7.131974e-3 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 7.132950e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 7.256751e-3 |
GO:0021978 | telencephalon regionalization | 7.351491e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 7.596737e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 7.758035e-3 |
GO:0065002 | intracellular protein transmembrane transport | 7.758035e-3 |
GO:0034970 | histone H3-R2 methylation | 7.758035e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 7.758035e-3 |
GO:0032065 | cortical protein anchoring | 7.758035e-3 |
GO:0003210 | cardiac atrium formation | 7.758035e-3 |
GO:0003236 | sinus venosus morphogenesis | 7.758035e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 7.758035e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 7.764942e-3 |
GO:0003350 | pulmonary myocardium development | 7.764942e-3 |
GO:0070170 | regulation of tooth mineralization | 7.764942e-3 |
GO:0006184 | GTP catabolic process | 7.803066e-3 |
GO:0034259 | negative regulation of Rho GTPase activity | 7.812925e-3 |
GO:0070625 | zymogen granule exocytosis | 7.812925e-3 |
GO:0044314 | protein K27-linked ubiquitination | 7.812925e-3 |
GO:0000059 | protein import into nucleus, docking | 7.812925e-3 |
GO:0014057 | positive regulation of acetylcholine secretion | 7.812925e-3 |
GO:0072193 | ureter smooth muscle cell differentiation | 7.846101e-3 |
GO:0016584 | nucleosome positioning | 7.846101e-3 |
GO:0006397 | mRNA processing | 7.883731e-3 |
GO:0061034 | olfactory bulb mitral cell layer development | 8.161671e-3 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 8.231679e-3 |
GO:0021871 | forebrain regionalization | 8.252713e-3 |
GO:0008380 | RNA splicing | 8.331168e-3 |
GO:0021570 | rhombomere 4 development | 8.478556e-3 |
GO:0000096 | sulfur amino acid metabolic process | 8.581832e-3 |
GO:0071470 | cellular response to osmotic stress | 8.604538e-3 |
GO:0021527 | spinal cord association neuron differentiation | 8.990563e-3 |
GO:0021884 | forebrain neuron development | 9.123042e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 9.180459e-3 |
GO:0021604 | cranial nerve structural organization | 9.217835e-3 |
GO:0090231 | regulation of spindle checkpoint | 9.261846e-3 |
GO:0006540 | glutamate decarboxylation to succinate | 9.334541e-3 |
GO:0018022 | peptidyl-lysine methylation | 9.383563e-3 |
GO:0006396 | RNA processing | 9.445530e-3 |
GO:0015937 | coenzyme A biosynthetic process | 9.833799e-3 |
GO:0007064 | mitotic sister chromatid cohesion | 9.861670e-3 |
GO:0000271 | polysaccharide biosynthetic process | 1.020559e-2 |
GO:0061198 | fungiform papilla formation | 1.021649e-2 |
GO:0061312 | BMP signaling pathway involved in heart development | 1.021649e-2 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.021649e-2 |
GO:0060449 | bud elongation involved in lung branching | 1.049255e-2 |
GO:0060716 | labyrinthine layer blood vessel development | 1.058484e-2 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.088063e-2 |
GO:0060376 | positive regulation of mast cell differentiation | 1.088063e-2 |
GO:0010845 | positive regulation of reciprocal meiotic recombination | 1.088063e-2 |
GO:0003127 | detection of nodal flow | 1.088063e-2 |
GO:0072197 | ureter morphogenesis | 1.098083e-2 |
GO:0046847 | filopodium assembly | 1.113571e-2 |
GO:0060711 | labyrinthine layer development | 1.121633e-2 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 1.144203e-2 |
GO:0034968 | histone lysine methylation | 1.152708e-2 |
GO:0031577 | spindle checkpoint | 1.155932e-2 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.225563e-2 |
GO:0030035 | microspike assembly | 1.233778e-2 |
GO:0014037 | Schwann cell differentiation | 1.237673e-2 |
GO:0046502 | uroporphyrinogen III metabolic process | 1.242967e-2 |
GO:0061360 | optic chiasma development | 1.242967e-2 |
GO:0035799 | ureter maturation | 1.242967e-2 |
GO:2000597 | positive regulation of optic nerve formation | 1.242967e-2 |
GO:0021633 | optic nerve structural organization | 1.242967e-2 |
GO:0007144 | female meiosis I | 1.242967e-2 |
GO:0021650 | vestibulocochlear nerve formation | 1.242967e-2 |
GO:0035562 | negative regulation of chromatin binding | 1.242967e-2 |
GO:0001844 | protein insertion into mitochondrial membrane involved in induction of apoptosis | 1.245564e-2 |
GO:0009994 | oocyte differentiation | 1.248980e-2 |
GO:0072300 | positive regulation of metanephric glomerulus development | 1.265232e-2 |
GO:0061196 | fungiform papilla development | 1.265232e-2 |
GO:0032929 | negative regulation of superoxide anion generation | 1.290207e-2 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 1.299191e-2 |
GO:0031365 | N-terminal protein amino acid modification | 1.302279e-2 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.349419e-2 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.351679e-2 |
GO:0048561 | establishment of organ orientation | 1.356129e-2 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.356129e-2 |
GO:0071104 | response to interleukin-9 | 1.356129e-2 |
GO:0042664 | negative regulation of endodermal cell fate specification | 1.356129e-2 |
GO:0008295 | spermidine biosynthetic process | 1.356129e-2 |
GO:0009088 | threonine biosynthetic process | 1.356129e-2 |
GO:0021764 | amygdala development | 1.356129e-2 |
GO:0040040 | thermosensory behavior | 1.356129e-2 |
GO:0070672 | response to interleukin-15 | 1.366932e-2 |
GO:0048143 | astrocyte activation | 1.379840e-2 |
GO:0006370 | mRNA capping | 1.379840e-2 |
GO:0010891 | negative regulation of sequestering of triglyceride | 1.398676e-2 |
GO:0003218 | cardiac left ventricle formation | 1.404911e-2 |
GO:0048599 | oocyte development | 1.417384e-2 |
GO:0000209 | protein polyubiquitination | 1.437545e-2 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.454235e-2 |
GO:0007041 | lysosomal transport | 1.470897e-2 |
GO:0060125 | negative regulation of growth hormone secretion | 1.482843e-2 |
GO:0051463 | negative regulation of cortisol secretion | 1.482843e-2 |
GO:0007057 | spindle assembly involved in female meiosis I | 1.482843e-2 |
GO:0021920 | regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification | 1.482843e-2 |
GO:0035502 | metanephric ureteric bud development | 1.482843e-2 |
GO:0034660 | ncRNA metabolic process | 1.490574e-2 |
GO:2000171 | negative regulation of dendrite development | 1.494559e-2 |
GO:0051204 | protein insertion into mitochondrial membrane | 1.494559e-2 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.494559e-2 |
GO:0060914 | heart formation | 1.500168e-2 |
GO:0060921 | sinoatrial node cell differentiation | 1.523232e-2 |
GO:0030031 | cell projection assembly | 1.538793e-2 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 1.551165e-2 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 1.551165e-2 |
GO:0048665 | neuron fate specification | 1.564673e-2 |
GO:0034241 | positive regulation of macrophage fusion | 1.579185e-2 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 1.579185e-2 |
GO:0035750 | protein localization to myelin sheath abaxonal region | 1.579185e-2 |
GO:0019047 | provirus integration | 1.579185e-2 |
GO:0006409 | tRNA export from nucleus | 1.579185e-2 |
GO:0006666 | 3-keto-sphinganine metabolic process | 1.579185e-2 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 1.579185e-2 |
GO:0043524 | negative regulation of neuron apoptosis | 1.590141e-2 |
GO:0090192 | regulation of glomerulus development | 1.614778e-2 |
GO:0006364 | rRNA processing | 1.616534e-2 |
GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 1.647182e-2 |
GO:0071544 | diphosphoinositol polyphosphate catabolic process | 1.647182e-2 |
GO:0010172 | embryonic body morphogenesis | 1.654916e-2 |
GO:0072044 | collecting duct development | 1.671940e-2 |
GO:0042133 | neurotransmitter metabolic process | 1.681725e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 1.683454e-2 |
GO:0016572 | histone phosphorylation | 1.683454e-2 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.695919e-2 |
GO:0034653 | retinoic acid catabolic process | 1.695919e-2 |
GO:0006465 | signal peptide processing | 1.703237e-2 |
GO:0010498 | proteasomal protein catabolic process | 1.707747e-2 |
GO:0003181 | atrioventricular valve morphogenesis | 1.710683e-2 |
GO:0035117 | embryonic arm morphogenesis | 1.710759e-2 |
GO:0034441 | plasma lipoprotein particle oxidation | 1.755728e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 1.755728e-2 |
GO:0019388 | galactose catabolic process | 1.755728e-2 |
GO:0001893 | maternal placenta development | 1.757039e-2 |
GO:0042490 | mechanoreceptor differentiation | 1.773252e-2 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.814092e-2 |
GO:0072015 | glomerular visceral epithelial cell development | 1.814793e-2 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.814793e-2 |
GO:0048793 | pronephros development | 1.820800e-2 |
GO:0051028 | mRNA transport | 1.867895e-2 |
GO:0090303 | positive regulation of wound healing | 1.868511e-2 |
GO:0021571 | rhombomere 5 development | 1.868511e-2 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 1.868511e-2 |
GO:0016072 | rRNA metabolic process | 1.871248e-2 |
GO:0045906 | negative regulation of vasoconstriction | 1.883715e-2 |
GO:0006538 | glutamate catabolic process | 1.883715e-2 |
GO:0032508 | DNA duplex unwinding | 1.890041e-2 |
GO:0072498 | embryonic skeletal joint development | 1.922467e-2 |
GO:2000142 | regulation of transcription initiation, DNA-dependent | 1.952186e-2 |
GO:0008333 | endosome to lysosome transport | 1.962314e-2 |
GO:0090224 | regulation of spindle organization | 2.029276e-2 |
GO:0038007 | netrin-activated signaling pathway | 2.031776e-2 |
GO:0034214 | protein hexamerization | 2.031776e-2 |
GO:0051013 | microtubule severing | 2.031776e-2 |
GO:0021623 | oculomotor nerve formation | 2.031776e-2 |
GO:0003404 | optic vesicle morphogenesis | 2.031776e-2 |
GO:0003409 | optic cup structural organization | 2.031776e-2 |
GO:0043217 | myelin maintenance | 2.051665e-2 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.057674e-2 |
GO:0045778 | positive regulation of ossification | 2.081697e-2 |
GO:0070734 | histone H3-K27 methylation | 2.088220e-2 |
GO:0006288 | base-excision repair, DNA ligation | 2.088220e-2 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.089156e-2 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 2.094300e-2 |
GO:0060113 | inner ear receptor cell differentiation | 2.111250e-2 |
GO:0070244 | negative regulation of thymocyte apoptosis | 2.147017e-2 |
GO:0010454 | negative regulation of cell fate commitment | 2.155059e-2 |
GO:0001834 | trophectodermal cell proliferation | 2.159411e-2 |
GO:0045064 | T-helper 2 cell differentiation | 2.159411e-2 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 2.172114e-2 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 2.174173e-2 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.185018e-2 |
GO:0021562 | vestibulocochlear nerve development | 2.187280e-2 |
GO:0018126 | protein hydroxylation | 2.187280e-2 |
GO:0051329 | interphase of mitotic cell cycle | 2.197822e-2 |
GO:0051901 | positive regulation of mitochondrial depolarization | 2.240546e-2 |
GO:0021549 | cerebellum development | 2.262851e-2 |
GO:0009082 | branched chain family amino acid biosynthetic process | 2.267109e-2 |
GO:0030521 | androgen receptor signaling pathway | 2.270080e-2 |
GO:0051351 | positive regulation of ligase activity | 2.301384e-2 |
GO:0051926 | negative regulation of calcium ion transport | 2.301384e-2 |
GO:0060066 | oviduct development | 2.307473e-2 |
GO:0003406 | retinal pigment epithelium development | 2.319023e-2 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.319023e-2 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 2.319023e-2 |
GO:0019941 | modification-dependent protein catabolic process | 2.360846e-2 |
GO:0034635 | glutathione transport | 2.376416e-2 |
GO:0003278 | apoptosis involved in heart morphogenesis | 2.376416e-2 |
GO:0032074 | negative regulation of nuclease activity | 2.376416e-2 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 2.398858e-2 |
GO:0006434 | seryl-tRNA aminoacylation | 2.398858e-2 |
GO:0006420 | arginyl-tRNA aminoacylation | 2.398858e-2 |
GO:0006424 | glutamyl-tRNA aminoacylation | 2.398858e-2 |
GO:0003015 | heart process | 2.400343e-2 |
GO:0090193 | positive regulation of glomerulus development | 2.410395e-2 |
GO:0016188 | synaptic vesicle maturation | 2.410395e-2 |
GO:0060789 | hair follicle placode formation | 2.410395e-2 |
GO:0030433 | ER-associated protein catabolic process | 2.425316e-2 |
GO:0044253 | positive regulation of multicellular organismal metabolic process | 2.431046e-2 |
GO:0021681 | cerebellar granular layer development | 2.447816e-2 |
GO:0032392 | DNA geometric change | 2.447816e-2 |
GO:0045839 | negative regulation of mitosis | 2.448372e-2 |
GO:0060272 | embryonic skeletal joint morphogenesis | 2.452946e-2 |
GO:0043064 | flagellum organization | 2.452946e-2 |
GO:0051325 | interphase | 2.477682e-2 |
GO:0000045 | autophagic vacuole assembly | 2.511775e-2 |
GO:0072095 | regulation of branch elongation involved in ureteric bud branching | 2.523072e-2 |
GO:2000649 | regulation of sodium ion transmembrane transporter activity | 2.529560e-2 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 2.529560e-2 |
GO:0071281 | cellular response to iron ion | 2.538017e-2 |
GO:0090187 | positive regulation of pancreatic juice secretion | 2.610798e-2 |
GO:0090340 | positive regulation of secretion of lysosomal enzymes | 2.610798e-2 |
GO:0051545 | negative regulation of elastin biosynthetic process | 2.610798e-2 |
GO:0090108 | positive regulation of high-density lipoprotein particle assembly | 2.610798e-2 |
GO:0006653 | 1,2-diacyl-sn-glycero-3-phosphocholine metabolic process | 2.610798e-2 |
GO:0060026 | convergent extension | 2.615563e-2 |